Stock futures ticked up on Sunday evening as investors prepare for a slate of inflation data on Wednesday and Thursday and brace for the start of the second-quarter earnings season.
Futures tied to the Dow Jones Industrial Average added 38 points, or 0.1%. Nasdaq 100 futures climbed 0.01% while S&P 500 futures gained about 0.1%.
This week’s inflation data follows a rate hike skip at the June Federal Open Market Committee meeting. The consumer price index report is due out Wednesday morning, followed by the central bank’s preferred gauge of wholesale price pressures, the producer price index, on Thursday.
With that we would like to draw your attention to Mangoceuticals, Inc. (NASDAQ:MGRX).
MGRX is a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated drug branded “Mango,”.
Recently, the company announced the launch of its new “Make America Hard Again” nationwide marketing campaign and website, www.MakeAmericaHardAgain.com. The newly launched Make America Hard Again web presence will be optimized for lead traffic generation and will be dedicated to driving revenue through the sale of Make America Hard Again and MangoRx related merchandise, with the optimum goal of creating awareness around the MangoRx brand and driving web traffic toward www.MangoRx.com. (Source: https://finance.yahoo.com/news/mangoceuticals-launches-america-hard-again-140000145.html)
MGRX Company’s Co-Founder and CEO, Jacob Cohen, along with the MangoRx family, including Company officials and members of the executive management team, rang the Nasdaq Closing Bell on Thursday, May 18, 2023. Since then, MGRX has been on a roll to promote its flagship product. For more info on MGRX, visit https://finance.yahoo.com/quote/MGRX
MGRX also recently aannounced its new collaboration with Ice Shaker to supply custom-made Mango-branded Ice Shaker bottles to be sold exclusively on the company’s new MakeAmericaHardAgain.com e-commerce portal.
MGRX is trading at a significant discount from its ipo pricing. The stock appears to be consolidating at the $1.7 mark and with more news a break out could be imminent. As always conduct your own research and follow traders vigilance.
JPMorgan Chase and Citigroup, as well as Delta Air Lines are slated to post their latest quarterly results. Snack and beverage giant PepsiCo is also on deck.
Expectations for this earnings season are downbeat, with analysts forecasting a roughly 7% year-over-year drop, FactSet data shows. That said, recent data points to a resilient economy — even as the Federal Reserve raises rates — and could bode well for companies.
Disclaimer: Please make sure to completly read and understand our disclaimer at Investorbrandmedia.com/disclaimer. This is a compensated post.
